Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Exelixis
Related studies linked through entity extraction aliases.
Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone
- Status
- TERMINATED
- Phase
- PHASE2
A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BMS-863233 in Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 1 Study of XL019 in Adults With Polycythemia Vera
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib
- Status
- COMPLETED
- Phase
- PHASE2